| Title | Clinical Breast Cancer |
| Abbreviation | Clin. Breast Cancer |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q2); Oncology (Q2) |
| h-index | 74 |
| Overall Rank/Ranking | 5340 |
| SCImago Journal Rank (SJR) | 0.862 |
| Impact Score | 3.01 |
| Publisher | Elsevier |
| Country | United States |
| ISSN | 15268209, 19380666 |
| Best Quartile | Q2 |
| Coverage History | 2000-2022 |
Clinical Breast Cancer is a tumor-specific, peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer.
Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer.
Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
Clinical Breast Cancer is a journal covering the technologies/fields/categories related to Cancer Research (Q2); Oncology (Q2). It is published by Elsevier. The overall rank of Clinical Breast Cancer is 5340. According to SCImago Journal Rank (SJR), this journal is ranked 0.862. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 74. The best quartile for this journal is Q2.
The ISSN of Clinical Breast Cancer journal is 15268209, 19380666. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical Breast Cancer is cited by a total of 1348 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Clinical Breast Cancer is 3.01, which is computed in 2023 as per its definition. Clinical Breast Cancer IF is increased by a factor of 0.21 and approximate percentage change is 7.5% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Clinical Breast Cancer is 3.01. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.01 |
| 2021 | 2.80 |
| 2020 | 2.94 |
| 2019 | 2.52 |
| 2018 | 2.38 |
| 2017 | 2.61 |
| 2016 | 2.42 |
| 2015 | 3.07 |
| 2014 | 2.52 |
Clinical Breast Cancer has an h-index of 74. It means 74 articles of this journal have more than 74 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Clinical Breast Cancer is 15268209, 19380666. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Clinical Breast Cancer is 5340. According to SCImago Journal Rank (SJR), this journal is ranked 0.862. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.862 |
| 2021 | 0.824 |
| 2020 | 1.078 |
| 2019 | 1.142 |
| 2018 | 1.068 |
| 2017 | 1.000 |
| 2016 | 1.115 |
| 2015 | 1.038 |
| 2014 | 1.163 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 5340 |
| 2021 | 5493 |
| 2020 | 3907 |
| 2019 | 3518 |
| 2018 | 3948 |
| 2017 | 4358 |
| 2016 | 3743 |
| 2015 | 4212 |
| 2014 | 3472 |
Clinical Breast Cancer is published by Elsevier. It's publishing house is located in United States. Coverage history of this journal is as following: 2000-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Clinical Breast Cancer is Clin. Breast Cancer. This abbreviation ('Clin. Breast Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q2); Oncology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Clinical Breast Cancer latest impact IF is 3.01. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.07 (2015) and 2.38 (2018), respectively, in the last 9 years. Moreover, its average IS is 2.7 in the previous 9 years.
The Clinical Breast Cancer has an SJR (SCImago Journal Rank) of 0.862, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.163 in 2014 and the lowest being 0.824 in 2021. Furthermore, the average SJR of the Clinical Breast Cancer over the previous 9-year period stands at 2.7.
The latest h-index of the Clinical Breast Cancer is 74.
The Clinical Breast Cancer is published by the Elsevier, with its country of publication being the United States.
The Clinical Breast Cancer is currently ranked 5340 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 3472 in 2014 and its lowest position of 5493 in 2021.
The standard ISO4 abbreviation for the Clinical Breast Cancer is Clin. Breast Cancer.
Clinical Breast Cancer is classified as a journal that the Elsevier publishes.
The Clinical Breast Cancer encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Clinical Breast Cancer is assigned the following International Standard Serial Numbers (ISSN): 15268209, 19380666.
The best quartile for the Clinical Breast Cancer is Q2 (2022).
The Clinical Breast Cancer coverage history can be summarized as follows: 2000-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| Mathematical Modelling and Analysis | journal | 11315 | Vilnius Gediminas Technical University | 27 | 1.75 |
| Child and Family Social Work | journal | 8628 | Wiley-Blackwell Publishing Ltd | 67 | 2.20 |
| Journal of Education and Work | journal | 9268 | Brill Academic Publishers | 43 | 1.93 |
| Modern Language Journal | journal | 918 | Wiley-Blackwell | 103 | 3.89 |
| Transnational Corporations | journal | 6120 | UNCTAD United Nations Conference on Trade and Development | 27 | 1.92 |
| Indian Phytopathology | journal | 14222 | Springer Nature | 11 | 1.33 |
| SPE International Formation Damage Control Symposium Proceedings | conference and proceedings | 21934 | 16 | 0.00 | |
| Journal of Evolutionary Psychology | journal | 28897 | Akademiai Kiado | 0 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.01 |
| 2021 | 2.80 |
| 2020 | 2.94 |
| 2019 | 2.52 |
| 2018 | 2.38 |
| 2017 | 2.61 |
| 2016 | 2.42 |
| 2015 | 3.07 |
| 2014 | 2.52 |
